KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Gross Margin (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 299.00
Dec 31, 2025 -467.00
Sep 30, 2025 -62.00
Jun 30, 2025 -41.00
Mar 31, 2025 1,191.00
Dec 31, 2024 -1,412.00
Sep 30, 2024 191.00
Jun 30, 2024 -207.00
Mar 31, 2024 -79.00
Dec 31, 2023 -106.00
Sep 30, 2023 277.00
Jun 30, 2023 -299.00
Mar 31, 2023 10.00
Dec 31, 2022 -176.00
Sep 30, 2022 191.00
Jun 30, 2022 -167.00
Mar 31, 2022 -156.00
Dec 31, 2021 5.00
Sep 30, 2021 124.00
Jun 30, 2021 471.00
Mar 31, 2021 64.00
Dec 31, 2020 -255.00
Sep 30, 2020 291.00
Jun 30, 2020 732.00
Mar 31, 2020 -260.00
Dec 31, 2019 -157.00
Sep 30, 2019 164.00
Jun 30, 2019 -63.00
Mar 31, 2019 -386.00
Dec 31, 2018 200.00
Sep 30, 2018 -47.00
Jun 30, 2018 201.00
Mar 31, 2018 -112.00
Dec 31, 2017 67.00
Sep 30, 2017 45.00
Jun 30, 2017 -484.00
Mar 31, 2017 115.00
Dec 31, 2016 -30.00
Sep 30, 2016 -175.00
Jun 30, 2016 -80.00
Mar 31, 2016 -175.00
Dec 31, 2015 475.00
Sep 30, 2015 -263.00
Jun 30, 2015 -337.00
Mar 31, 2015 173.00
Dec 31, 2014 300.00
Sep 30, 2014 -20.00
Jun 30, 2014 -8.00
Mar 31, 2014 326.00
Dec 31, 2013 24.00
Sep 30, 2013 -153.00
Jun 30, 2013 38.00
Mar 31, 2013 -210.00
Dec 31, 2012 77.00
Sep 30, 2012 160.00
Jun 30, 2012 -321.00
Mar 31, 2012 25.00
Dec 31, 2011 126.00
Sep 30, 2011 93.00
Jun 30, 2011 -45.00
Mar 31, 2011 86.00
Dec 31, 2010 -99.00
Sep 30, 2010 10.00
Jun 30, 2010 39.00
Mar 31, 2010 130.00
Dec 31, 2009 -97.00
Sep 30, 2009 -125.00
Jun 30, 2009 70.00